News for Oxygen Biotherapeutics, Inc. - Google Finance

Oxygen Biotherapeutics Names Col. Charles L. Pamplin III, M.D., Chief Medical ...

Thu, 23 May 2013 10:33:34 GMT

Oxygen Biotherapeutics Names Col. Charles L. Pamplin III, M.D., Chief Medical ...
Business Wire (press release) - May 23, 2013

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (“OBI”) (NASDAQ: OXBT), today announced Col. (ret.

OXYGEN BIOTHERAPEUTICS, INC. : Oxygen Biotherapeutics Receives ...

Thu, 16 May 2013 14:27:36 GMT

OXYGEN BIOTHERAPEUTICS, INC. : Oxygen Biotherapeutics Receives ...
4-traders (press release) - May 16, 2013

Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), today announced that the NASDAQ Listing Qualifications Panel (the "Panel") has granted the Company's request for continued listing on The NASDAQ Capital Market pursuant to an extension through June 3, ...

Oxygen Biotherapeutics Receives Favorable NASDAQ Listing Decision - MarketWatch (press release)

OXYGEN BIOTHERAPEUTICS, INC. : Oxygen Biotherapeutics Announces It is ...

Tue, 30 Apr 2013 12:11:09 GMT

OXYGEN BIOTHERAPEUTICS, INC. : Oxygen Biotherapeutics Announces It is ...
4-traders (press release) - Apr 30, 2013

Oxygen Biotherapeutics, Inc. ("OBI") (NASDAQ: OXBT), today announced the initiation of the second cohort of its Phase IIb clinical trial to investigate the safety and tolerability of Oxycyte in patients with severe, non-penetrating traumatic brain ...

Oxygen Biotherapeutics Announces It is Set to Begin Enrolling Patients in the ... - MarketWatch (press release)

Stocks Up For The Day: Oxygen Biotherapeutics Inc. (NASDAQ:OXBT), Cardium ...

Sun, 28 Apr 2013 23:29:12 GMT

Stocks Up For The Day: Oxygen Biotherapeutics Inc. (NASDAQ:OXBT), Cardium ...
NIS - Apr 28, 2013

New York, NY - (NISMAGAZINE) - 4/28/2013- Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) gained 12.45% at $0.225 after trading 120,062 shares.

CYCC, OMER To Watch Out, LGND Adds To Portfolio, TTHI, RPTP, Trimel Spike

Wed, 01 May 2013 03:09:09 GMT

CYCC, OMER To Watch Out, LGND Adds To Portfolio, TTHI, RPTP, Trimel Spike
NASDAQ - May 1, 2013

Oxygen Biotherapeutics Inc. ( OXBT ) is all set to begin enrolling patients in the second cohort of its phase IIb clinical trial to investigate the safety and tolerability of Oxycyte in patients with severe, non-penetrating traumatic brain injury.

Medical Instruments sector up 2.63 points or 0.12% to 2113.91 led by ISRG, SIRO

Wed, 01 May 2013 06:47:57 GMT

Medical Instruments sector up 2.63 points or 0.12% to 2113.91 led by ISRG, SIRO
Dentistry IQ - May 1, 2013

Company Name Last PVUS$1000 [1Wk] MGC Diagnostics Corporation (MGCD) US$7.0 1,187 Vermillion (VRML) US$1.35 1,164 Oxygen Biotherapeutics (OXBT) 24.99c 1,152 Imris Inc (IMRS) US$3.19 1,150 Uroplasty, Inc. (UPI) US$2.49 1,117. Bottom 5 ...

Medical Instruments sector up 6.61 points or 0.31% to 2111.28 led by ISRG, HOLX

Tue, 30 Apr 2013 05:30:27 GMT

Medical Instruments sector up 6.61 points or 0.31% to 2111.28 led by ISRG, HOLX
Dentistry IQ - Apr 30, 2013

... (UPI) keeps rising: up 21.4% in 3 days US$2.67 18c [7.2%] 0.7 Bioanalytical Systems (BASI) climbs 4.7% on below average volume US$1.55 7c [4.7%] 0.8 UPDATE: Oxygen Biotherapeutics (OXBT) keeps rising: up 17.5% in 2 days 23.50c 1.01c [4.5%] 0.5 ...

Medical Instruments sector up 10.35 points or 0.49% to 2104.67 led by ISRG ...

Sat, 27 Apr 2013 08:41:06 GMT

Medical Instruments sector up 10.35 points or 0.49% to 2104.67 led by ISRG ...
Dentistry IQ - Apr 27, 2013

UPDATE: Oxygen Biotherapeutics (OXBT) soars 12.4% on average volume 22.49c 2.49c [12.4%] 1 UPDATE: Urologix (ULGX) soars 11.6% on strong volume 48.0c 5c [11.6%] 5.3 MGC Diagnostics (MGCD) rises to test 7.0 US$7.24 74c [11.4%] 0.4 Uroplasty (UPI ...

Oxygen Biotherapeutics Inc Enters Into Definitive Agreements For Financing For Up To $2.1 Million In Gross Proceeds

Fri, 22 Feb 2013 13:58:00 GMT

Oxygen Biotherapeutics Inc Enters Into Definitive Agreements For Financing For Up To $2.1 Million In Gross Proceeds
Reuters Key Development - Feb 22, 2013

Oxygen Biotherapeutics Inc Announces Tentative Settlement Of Litigation

Wed, 20 Feb 2013 16:03:00 GMT

Oxygen Biotherapeutics Inc Announces Tentative Settlement Of Litigation
Reuters Key Development - Feb 20, 2013